Mortality indicators in pneumococcal meningitis: therapeutic implications

Pneumococcal infections
DOI: 10.1016/j.ijid.2013.09.012 Publication Date: 2013-10-30T03:30:55Z
ABSTRACT
BackgroundThe aim of this study was to delineate mortality indicators in pneumococcal meningitis with special emphasis on therapeutic implications.MethodsThis retrospective, multicenter cohort involved a 15-year period (1998–2012). Culture-positive cases (n = 306) were included solely from 38 centers.ResultsFifty-eight patients received ceftriaxone plus vancomycin empirically. The rest given third-generation cephalosporin alone. Overall, 246 (79.1%) isolates found be penicillin-susceptible, (12.2%) strains penicillin-resistant, and 22 (7.1%) oxacillin-resistant (without further minimum inhibitory concentration testing for penicillin). Being critical case (odds ratio (OR) 7.089, 95% confidence interval (CI) 3.230–15.557) age over 50 years (OR 3.908, CI 1.820–8.390) independent predictors mortality, while infection penicillin-susceptible isolate 0.441, 0.195–0.996) protective. Empirical use did not provide significant benefit 2.159, 0.949–4.912).ConclusionsCeftriaxone alone is adequate the management due penicillin-resistant pneumococci, which major concern worldwide. Although showed trend towards improving prognosis meningitis, correlation statistical terms could established study. Thus, studies are needed optimization treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....